Raymond: Appoints Deepal Shah as President – Strategy & Special Projects

Raymond Limited has announced the appointment of Mr. Deepal Shah as President – Strategy & Special Projects, effective July 31, 2026. Mr. Shah, a Chartered Accountant with over two decades of leadership experience in business and finance, brings a wealth of expertise in global IT transformation, large-scale acquisitions, and strategic initiatives. His extensive background is expected to significantly contribute to the company’s group-wide strategic objectives.

New Leadership Appointment

Raymond Limited has officially appointed Mr. Deepal Shah to the significant role of President – Strategy & Special Projects. This appointment is effective from July 31, 2026, and classifies Mr. Shah as Senior Management Personnel (SMP) within the company. The company is adhering to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, for this disclosure.

Deepal Shah’s Profile and Experience

Mr. Deepal Shah is a distinguished Chartered Accountant who has also completed advanced management programs at prestigious institutions such as the Indian School of Business, Jamnalal Bajaj Institute of Management Studies, and Kellogg School of Management. His career spans over two decades, marked by successful leadership in both CEO and CFO capacities, both globally and within India.

His expertise encompasses navigating complex business and finance landscapes. He has a proven track record in leading global IT transformation projects, managing substantial large-scale acquisitions, and overseeing mergers and alliances. This diverse experience makes him exceptionally well-suited to drive Raymond’s group-wide strategic initiatives. Mr. Shah has previously held key leadership positions in prominent organizations including All Cargo, DHL, and ITC Group, contributing to advancements in Finance, Global Networks, IT, strategic planning, and business development.

Commitment to Transparency

The relevant details pertaining to this appointment, as per SEBI Listing Regulations and the Master Circular dated January 30, 2026, are provided. Further information on this appointment is also available on the company’s official website at https://www.raymond.in.

Source: BSE

Previous Article

Strides Pharma: Reports Q1 FY27 Consolidated Unaudited Results

Next Article

UTI Mutual Fund: Appoints Narayan Subramaniam Ayypankav as Independent Director